Standardisation of a coproantigen reduction test (CRT) protocol for the diagnosis of resistance to triclabendazole in Fasciola hepatica

A.M. Flanagan, H.W.J. Edgar, F. Forster, A. Gordon, Ronnie Hanna, M. McCoy, Gerard Brennan, Ian Fairweather

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

A sheep trial was performed to standardise a coproantigen reduction test (CRT) protocol for the diagnosis of resistance to triclabendazole (TCBZ) in Fasciola hepatica). The CRT employs the BIO K201 Fasciola coproantigen ELISA (Bio-X Diagnostics, Jemelle, Belgium) to test for the presence of F. hepatica coproantigens in a faecal sample. If it is coproantigen-positive, the CRT protocol recommends that faecal samples are re-tested for coproantigens at 14 days post-treatment (dpt), with negative testing at this point indicating TCBZ success.
Original languageEnglish
Pages (from-to)34-42
Number of pages9
JournalVeterinary Parasitology
Volume176
Issue number1
DOIs
Publication statusPublished - 28 Feb 2011

ASJC Scopus subject areas

  • Parasitology
  • veterinary(all)

Fingerprint Dive into the research topics of 'Standardisation of a coproantigen reduction test (CRT) protocol for the diagnosis of resistance to triclabendazole in Fasciola hepatica'. Together they form a unique fingerprint.

Cite this